Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage: Phase III Clinical Trial

NCT03390530 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT03390530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage: Phase III Clinical Trial
Lead sponsor
Albert Einstein College of Medicine
Phase
Phase 3
Overall status
Withdrawn
Start date
January 18, 2022
Completion date
January 18, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraventricular hemorrhage of prematurity